期刊文献+

纳米粒载体研发及其对生物效应影响的研究进展 被引量:4

Research Progress of Nanoparticle Carriers and Their Biological Effects
原文传递
导出
摘要 近年来,纳米粒作为药物载体在药剂领域得到广泛应用,特别是对一些难溶性和毒副作用大的药物,设计出不同的纳米药物载体可以达到增加溶解度和靶向治疗目的。纳米靶向给药系统可将药物特异性递送到靶部位,实现药物的控制释放,从而提高药物的生物利用度和疗效并减少毒副作用。纳米粒载体的性质不同,其在体内的生物效应是不同的。笔者对近年来各种聚合物材料制成的纳米粒大小,表面性质对体内的分布影响及常用的纳米粒载体在体内遇到的障碍,靶向纳米粒设计思路和其生物效应的研究进展进行综述。 In recent years, nanoparticle as drug carriers have been widely used in the pharmaceutical field. For some poorly solu- ble drugs or drugs with strong toxicity and side effects, the design of different nano drug carriers can help achieve improved solubility and targeted therapy. The nano targeted drug delivery system can deliver drug specifically to the target sites and realize controlled release of drugs, thereby increasing the bioavailability and efficacy of drugs and reducing the toxicity and side effects. In this paper, the recent progress in studies on the design of nanoparticles, their biological effects, and their application in the field of medicine are reviewed.
出处 《中国药学杂志》 CAS CSCD 北大核心 2017年第10期814-818,共5页 Chinese Pharmaceutical Journal
关键词 纳米粒 靶向性 生物有效性 难溶型药物 nanoparticle targeting bioavailability water-insoluble drug
  • 相关文献

参考文献1

二级参考文献26

  • 1S. Carrick, D. Ghersi, N. Wilcken, J. Simes, Platinum containing regimens for metastatic breast cancer, Cochrane Database Syst. Rev. (2OO4) CD003374, h ttp : J J dx.doi.orgJ l O. l OO2 J146518 58.CDOO3 3 7 4.pub 3.
  • 2G. Chu, Cellular-responses to cisplatin-the roles of DNA-binding proteins and DNA-repair, J. Biol. Chem. 269 (1994) 787-790.
  • 3D.C. lhde, J.L Mulshine, B.S. Kramer, et al, Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung-cancer, J. Clin. Oncol. 12 (1994) 2022-2034.
  • 4R.P. Perng, Y.M. Chen, M. Lu, et al., Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase 11 randomized study, J. Clin. Oncol. 15 (1997) 2097-2102.
  • 5B. Desoize, C. Madoulet, Particular aspects of platinum compounds used at present in cancer treatment, Crit. Rev. Oncol. Hematol. 42 (2002) 317-325.
  • 6Y. Kidani, K. lnagaki, M. ligo, A. Hoshi, K. Kuretani, Antitumor activity of 1,2- diaminocyclohexane-platinum complexes against sarcoma-lg0 ascites form, J. Med. Chem. 21 (1978) 1315-1318.
  • 7H. Cabral, N. Nishiyama, S. Okazaki, H. Koyama, K. Kataoka, Preparation and biological properties of dichloro(1,2-diaminocyclo-hexane) platinum (lI)(DACHPt)-loaded polymeric micelles, J. Control. Release 101 (2005) 223-232.
  • 8H. Cabral, N. Nishiyama, K. Kataoka, Optimization of (l,2-diamino-cyclohexane)- platinum(ll)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity, J. Control. Release 121 (2007) 146-155.
  • 9M. Murakami, H. Cabral, Y. Matsumoto, et al., Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting, Sci. Transl. Med. 3 (2011) 64ra2.
  • 10H. Cabral, Y. Matsumoto, K. Mizuno, et al., Accumulation of sub-100 nm polymeric micelles in poorly permeable turnouts depends on size, Nat. Nanotechnol. 6 (2011) 815-823.

共引文献2

同被引文献38

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部